Your browser is no longer supported. Please, upgrade your browser.
Settings
TSRO Tesaro, Inc. daily Stock Chart
TSRO [NASD]
Tesaro, Inc.
Index- P/E- EPS (ttm)-11.91 Insider Own0.10% Shs Outstand54.92M Perf Week-0.35%
Market Cap4.05B Forward P/E- EPS next Y-9.36 Insider Trans-16.22% Shs Float53.28M Perf Month151.59%
Income-648.60M PEG- EPS next Q-2.40 Inst Own- Short Float26.71% Perf Quarter111.03%
Sales219.40M P/S18.45 EPS this Y-16.80% Inst Trans8.19% Short Ratio4.18 Perf Half Y85.29%
Book/sh-2.38 P/B- EPS next Y14.10% ROA-83.30% Target Price71.44 Perf Year-11.25%
Cash/sh8.68 P/C8.49 EPS next 5Y19.00% ROE- 52W Range23.41 - 85.00 Perf YTD-11.08%
Dividend- P/FCF- EPS past 5Y-15.30% ROI-70.10% 52W High-13.31% Beta1.21
Dividend %- Quick Ratio2.80 Sales past 5Y- Gross Margin66.40% 52W Low214.78% ATR3.51
Employees715 Current Ratio3.40 Sales Q/Q-54.90% Oper. Margin- RSI (14)80.67 Volatility0.62% 8.55%
OptionableYes Debt/Eq- EPS Q/Q-435.30% Profit Margin- Rel Volume1.41 Prev Close74.49
ShortableYes LT Debt/Eq- EarningsNov 01 AMC Payout- Avg Volume3.41M Price73.69
Recom2.70 SMA2037.60% SMA5072.07% SMA20066.56% Volume4,817,561 Change-1.07%
Oct-01-18Initiated Cantor Fitzgerald Overweight $57
Sep-25-18Initiated Leerink Partners Outperform
Aug-15-18Downgrade Argus Buy → Hold
Aug-06-18Downgrade BofA/Merrill Buy → Neutral
May-07-18Reiterated Lake Street Buy $120 → $80
Feb-28-18Reiterated Barclays Equal Weight $135 → $90
Feb-22-18Upgrade Evercore ISI In-line → Outperform
Jan-18-18Reiterated Credit Suisse Outperform $190 → $150
Jan-16-18Reiterated Morgan Stanley Overweight $165 → $156
Dec-20-17Reiterated Citigroup Buy $216 → $135
Nov-15-17Upgrade Leerink Partners Mkt Perform → Outperform
Oct-23-17Resumed Piper Jaffray Neutral $117
Oct-23-17Initiated Barclays Equal Weight $135
Oct-12-17Initiated H.C. Wainwright Buy $158
Aug-17-17Initiated Evercore ISI In-line $121
Jul-07-17Initiated Gabelli & Co Buy $175
Jun-05-17Reiterated FBR & Co. Mkt Perform $200 → $195
May-10-17Reiterated FBR & Co. Mkt Perform $202 → $200
Apr-12-17Initiated Piper Jaffray Overweight $180
Apr-10-17Initiated Janney Neutral $141
Dec-14-18 05:33PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline TSRO GlobeNewswire
10:50AM  READ NOW: Monteverde & Associates PC Is Investigating The Tender Offer Of Tesaro, Inc. Set To Expire On January 14, 2019 - TSRO ACCESSWIRE
Dec-13-18 07:00PM  DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
03:26PM  CLASS ACTION UPDATE for APOG, RBBN (SONS and TSRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:30AM  Biotech Companies in the News ACCESSWIRE
08:32AM  Ghost Tree Capitals AUM, Returns and Holdings Insider Monkey
Dec-12-18 08:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline TSRO ACCESSWIRE
02:06PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of APOG, IGCC, NKTR, TSRO and APHA GlobeNewswire
01:40PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Dec-11-18 04:21PM  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
12:42PM  Gabelli Names Clovis As Top Pick, Calls The Biotech A Likely Takeout Candidate Benzinga
Dec-10-18 03:13PM  SHAREHOLDER ALERT: TRVN GOOG GOOGL CWH HON FIT SYF RYAAY TSRO MGI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
01:59PM  Here's Why Tesaro Rose 60.6% in November -- and Another 60% Since Motley Fool
09:30AM  Pawar Law Group Announces a Securities Class Action Lawsuit Against Tesaro, Inc. - TSRO ACCESSWIRE
07:00AM  Today's Research Reports on Trending Tickers: Tesaro and Celgene ACCESSWIRE
Dec-09-18 11:07AM  CLASS ACTION UPDATE for AQUA, TSRO, MDR and TX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Dec-07-18 04:44PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline TSRO GlobeNewswire
01:57PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AQUA, SONS, RBBN, TSRO, ATUS and BA GlobeNewswire
10:05AM  INVESTOR ALERT: Monteverde & Associates PC Launches an Investigation of the Board of Directors and Officers of Tesaro, Inc. - TSRO ACCESSWIRE
Dec-06-18 01:00PM  SHAREHOLDER ALERT: APOG SFIX GOOG GOOGL CWH ALGN SYF AQUA TSRO MGI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
11:48AM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Dec-05-18 07:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline TSRO ACCESSWIRE
03:11PM  CLASS ACTION UPDATE for GSKY, TSRO and TX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
08:23AM  GlaxoSmithKline's credit rating revised to negative at Moody's after Tesaro buyout deal MarketWatch
07:48AM  GlaxoSmithKline Capital Inc. -- Moody's changes GSK's outlook to negative; affirms A2 ratings Moody's
Dec-04-18 08:00PM  SHAREHOLDER ALERT: Monteverde & Associates PC Launches An Investigation of the Board of Directors and Officers of Tesaro, Inc. - TSRO PR Newswire
04:15PM  TESARO, Inc. Gives Notice of Anticipated Make-Whole Adjustment Event to Holders of Its Convertible Senior Notes GlobeNewswire
03:18PM  Wedbush Moves To The Sidelines On Tesaro Following Glaxo Deal Benzinga
02:30PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of JT, GOOG, AQUA, GSKY, TSRO and EIX GlobeNewswire
09:30AM  Company News For Dec 4, 2018 Zacks
08:27AM  Glaxo to Buy Zejula Maker TESARO for $5.1B, Stock Down 8% Zacks
08:06AM  TESARO Shares Rally on Glaxo's $5.1 Billion Buyout Offer Zacks
07:53AM  3 Big Stock Charts for Tuesday: Morgan Stanley, Ross Stores and Dominion Energy InvestorPlace
06:50AM  Today's Research Reports on Trending Tickers: Clovis Oncology and Tesaro ACCESSWIRE
06:11AM  Wellington, Fidelity, State Street could emerge winners from Tesaro acquisition American City Business Journals
Dec-03-18 09:03PM  Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Tesaro, Inc. (TSRO) on Behalf of Stockholders and Encourages TSRO Investors to Contact the Firm GlobeNewswire +58.47%
07:23PM  [$$] GlaxoSmithKline to Acquire Tesaro for $4.16 Billion The Wall Street Journal
04:30PM  Why Cronos Group, Tesaro, and Wynn Resorts Jumped Today Motley Fool
03:36PM  TESARO, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout Business Wire
01:33PM  Stock Market Rallies On China Trade News; Tesla Nears Breakout Investor's Business Daily
01:33PM  GlaxoSmithKline says it will keep Tesaro's Waltham HQ and staff American City Business Journals
01:12PM  CLASS ACTION UPDATE for RBBN and TSRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:00PM  Why GlaxoSmithKline, Clovis Oncology, and Tesaro Are on the Move Today Motley Fool
12:16PM  TSRO, GSK: Tesaro Stock Skyrockets on GlaxoSmithKline Deal InvestorPlace
12:14PM  [$$] GlaxoSmithKline to Acquire Tesaro for $4.16 Billion The Wall Street Journal
11:31AM  GSK slides after buying cancer firm Tesaro for hefty $5.1 billion Reuters
10:51AM  GSK slides after buying cancer firm Tesaro for hefty $5.1 billion Reuters
10:51AM  GlaxoSmithKline Stock Slumps on News of Tesaro Deal Barrons.com
10:40AM  SHAREHOLDER ALERT: WeissLaw LLP Investigates Tesaro, Inc. ACCESSWIRE
10:26AM  Glaxo's $5 Billion Takeover of Tesaro Seen as Too Expensive Bloomberg
10:07AM  GlaxoSmithKline Strikes $5B M&A Deal With Tesaro In Quest To Boost Oncology Franchise Benzinga
10:02AM  GlaxoSmithKline Makes $5.1 Billion Play for Cancer Drug Specialist Tesaro TheStreet.com
10:00AM  SHAREHOLDER ALERT- Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline - January 9, 2019 GlobeNewswire
09:54AM  Waltham's Tesaro to be acquired by GlaxoSmithKline for $5.1B American City Business Journals
09:38AM  GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro Associated Press
09:35AM  $5.1B deal: GSK to buy Boston-area cancer drug developer American City Business Journals
08:22AM  Tesaro surges 60% after GlaxoSmithKline agrees to buy it for $5.1 billion CNBC
08:00AM  Detailed Research: Economic Perspectives on TESARO, Regeneron Pharmaceuticals, Pool, Zebra Technologies, Cadence Design, and TherapeuticsMD What Drives Growth in Today's Competitive Landscape GlobeNewswire
07:50AM  Tesaro (TSRO) Alert: Johnson Fistel Investigates Proposed Sale of Tesaro, Inc. to GlaxoSmithKline plc; Are Shareholders Getting a Fair Deal? PR Newswire
07:18AM  Tesaro's stock rockets after $5.1 billion buyout deal with GlaxoSmithKline MarketWatch
07:04AM  GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company GlobeNewswire
06:59AM  Glaxo to buy Tesaro for $75 per share CNBC Videos
Dec-02-18 10:00AM  SHAREHOLDER ALERT: APOG SFIX DY FIT RYAAY TSRO MDR ATUS PPDF BA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Dec-01-18 09:31AM  Tesaro (TSRO) Up 45.5% Since Last Earnings Report: Can It Continue? Zacks
Nov-30-18 05:21PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline TSRO GlobeNewswire
03:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOOG, OZK, NKTR, FIT and TSRO GlobeNewswire
Nov-29-18 06:05PM  TSRO SHAREHOLDER NOTICE: Rosen Law Firm Reminds Tesaro, Inc. Investors of Important Deadline in Class Action TSRO Business Wire
11:59AM  CLASS ACTION UPDATE for TSRO, MGI and MDR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:00AM  SHAREHOLDER ALERT- Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline - January 9, 2019 GlobeNewswire
Nov-28-18 07:00AM  Today's Research Reports on Trending Tickers: Vertex Pharmaceuticals and Tesaro ACCESSWIRE
Nov-27-18 02:40PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Tesaro, Inc. TSRO ACCESSWIRE
01:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ALGN, RBBN, TSRO, EIX and MDR GlobeNewswire
11:11AM  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Nov-26-18 06:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline TSRO ACCESSWIRE
04:36PM  CLASS ACTION UPDATE for COST, TSRO and MGI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:21AM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tesaro, Inc. Business Wire
Nov-25-18 10:00AM  SHAREHOLDER ALERT: MGTI TRVN HTHT IGCC FIT SYF TSRO EIX MDR ATUS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Nov-23-18 06:25PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline TSRO GlobeNewswire
11:03AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of IGCC, AQUA, RBBN, TSRO, EIX and MDR GlobeNewswire
Nov-21-18 04:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline TSRO ACCESSWIRE
12:47PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
10:50AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of IGCC, FIT, SYF and TSRO GlobeNewswire
09:02AM  Clovis' (CLVS) Rubraca Gets Another US Patent, Shares Up Zacks
08:58AM  TESARO Shares Rally on Rumors of Potential Acquisition Offer Zacks
08:16AM  Can Deal Interest Help Tesaro Recover? Motley Fool
Nov-20-18 04:56PM  CLASS ACTION UPDATE for RBBN (formerly SONS) and TSRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire +15.34%
03:54PM  Here's Why Tesaro Is On the Move Today Motley Fool
08:33AM  TESARO (TSRO) Jumps: Stock Rises 5.4% Zacks
07:00AM  Today's Research Reports on Trending Tickers: Celgene and Tesaro ACCESSWIRE
Nov-19-18 04:28PM  SHAREHOLDER ALERT: APOG ALNY ACHC COST TRVN SFIX ALGN AQUA TSRO MGI MDR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire +5.35%
02:44PM  IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
12:23PM  Tesaro Stock Sinks in Aftermath of Sale Rumors InvestorPlace
09:35AM  Stock Market News Daily Roundup November 19 Market Exclusive
09:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline - January 9, 2019 ACCESSWIRE
Nov-18-18 10:15AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FIT, TSRO, MGI and MDR GlobeNewswire
Nov-16-18 06:21PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire +31.48%
05:07PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline TSRO GlobeNewswire
10:24AM  CLASS ACTION UPDATE for COST, TSRO and MGI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:33AM  SHAREHOLDER ALERT- Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline: January 9, 2019 ACCESSWIRE
Nov-14-18 04:04PM  SHAREHOLDER ALERT: APOG COCP COST TRVN HON DY ALGN AQUA SONS TSRO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire -11.27%
Tesaro, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States. It offers ZEJULA (niraparib), an orally active and potent poly polymerase inhibitor for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer; and VARUBI (rolapitant), a neurokinin-1, or NK-1, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. The company also develops Niraparib for the treatment of various tumors. In addition, it is developing immunotherapy antibody product candidates, including TSR-042, which is in a phase I clinical trial targeting programmed cell death protein 1; TSR-022 that is in phase I clinical trial targeting T-cell immunoglobulin domain and mucin domain-3; and TSR-033, an antibody candidate, which is in phase I clinical trial targeting lymphocyte-activation gene-3. The company has collaboration and exclusive license agreement with AnaptysBio, Inc., as well as collaboration agreements with Janssen Biotech, Inc., Millennium Pharmaceuticals, Inc., Zai Lab (Shanghai) Co., Ltd, Jiangsu Hengrui Medicine Co., Ltd., Merck Sharp & Dohme B.V., and Jiangsu Hengrui Medicine Co., Ltd., as well as Genentech. Tesaro, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Huber Martin H. Jr.SVP & Chief Medical OfficerSep 24Sale37.6337113,96112,206Sep 25 06:00 PM
Huber Martin H. Jr.SVP & Chief Medical OfficerSep 21Option Exercise0.001,250012,577Sep 25 06:00 PM
Oliveira OrlandoSVP & GM, InternationalSep 04Sale32.44722,33610,254Sep 05 05:04 PM
Oliveira OrlandoSVP & GM, InternationalSep 01Option Exercise0.001,250010,326Sep 05 05:04 PM
ORONSKY ARNOLD LDirectorAug 07Option Exercise0.0010,000012,479Aug 09 02:00 PM
ORONSKY ARNOLD LDirectorAug 07Sale26.7710,000267,7212,479Aug 09 02:00 PM
Farmer Joseph LSr VP, Gen Counsel & SecretaryAug 01Option Exercise0.0062508,479Aug 03 05:00 PM
Farmer Joseph LSr VP, Gen Counsel & SecretaryAug 01Sale34.371876,4278,292Aug 03 05:00 PM
Alleva Lawrence MDirectorJun 12Option Exercise6.627,14247,24437,044Jun 14 04:14 PM
Alleva Lawrence MDirectorJun 12Sale43.117,142307,92029,902Jun 14 04:14 PM
Oliveira OrlandoSVP & GM, InternationalMar 08Sale69.883,000209,6409,076Mar 09 05:14 PM
MOTT DAVID MDirectorMar 06Buy59.8215,793944,6659,681,129Mar 06 09:20 PM
NEW ENTERPRISE ASSOCIATES 13 L10% OwnerMar 06Buy59.8212,634755,7089,681,129Mar 06 09:19 PM
Viswanathan Ravi10% OwnerMar 06Buy59.8215,793944,6659,681,129Mar 06 09:16 PM
SANDELL SCOTT D10% OwnerMar 06Buy59.8215,793944,6659,681,129Mar 06 09:17 PM
BASKETT FOREST10% OwnerMar 06Buy59.8215,793944,6659,681,129Mar 06 09:11 PM
KERINS PATRICK J10% OwnerMar 06Buy59.8212,634755,7089,681,129Mar 06 09:11 PM
BARRETT M JAMES10% OwnerMar 06Buy59.8212,634755,7089,681,129Mar 06 09:10 PM
BARRIS PETER J10% OwnerMar 06Buy59.8215,793944,6659,681,129Mar 06 09:10 PM
MOTT DAVID MDirectorMar 05Buy58.8361,4373,614,3359,668,495Mar 06 09:20 PM
NEW ENTERPRISE ASSOCIATES 13 L10% OwnerMar 05Buy58.8349,1692,892,6009,668,495Mar 06 09:19 PM
Viswanathan Ravi10% OwnerMar 05Buy58.8361,4373,614,3359,668,495Mar 06 09:16 PM
SANDELL SCOTT D10% OwnerMar 05Buy58.8361,4373,614,3359,668,495Mar 06 09:17 PM
BASKETT FOREST10% OwnerMar 05Buy58.8361,4373,614,3359,668,495Mar 06 09:11 PM
KERINS PATRICK J10% OwnerMar 05Buy58.8349,1692,892,6009,668,495Mar 06 09:11 PM
BARRETT M JAMES10% OwnerMar 05Buy58.8349,1692,892,6009,668,495Mar 06 09:10 PM
BARRIS PETER J10% OwnerMar 05Buy58.8361,4373,614,3359,668,495Mar 06 09:10 PM
MOULDER LEON O JRChief Executive OfficerMar 02Buy56.935,000284,6405,000Mar 05 06:05 AM
MOTT DAVID MDirectorMar 02Buy55.5668,3023,795,1859,619,326Mar 06 09:20 PM
NEW ENTERPRISE ASSOCIATES 13 L10% OwnerMar 02Buy55.5654,6423,036,1699,619,326Mar 06 09:19 PM
Viswanathan Ravi10% OwnerMar 02Buy55.5668,3023,795,1859,619,326Mar 06 09:16 PM
SANDELL SCOTT D10% OwnerMar 02Buy55.5668,3023,795,1859,619,326Mar 06 09:17 PM
BASKETT FOREST10% OwnerMar 02Buy55.5668,3023,795,1859,619,326Mar 06 09:11 PM
KERINS PATRICK J10% OwnerMar 02Buy55.5654,6423,036,1699,619,326Mar 06 09:11 PM
BARRETT M JAMES10% OwnerMar 02Buy55.5654,6423,036,1699,619,326Mar 06 09:10 PM
BARRIS PETER J10% OwnerMar 02Buy55.5668,3023,795,1859,619,326Mar 06 09:10 PM
Farmer Joseph LSr.VP,Gen.Counsel & SecretaryMar 02Sale54.862,634144,5017,854Mar 05 05:26 PM
Huber Martin H. Jr.SVP & Chief Medical OfficerMar 02Sale54.861,80398,91311,327Mar 05 05:25 PM
PEARSON TIMOTHY RExec. VP, CFOMar 02Sale54.862,575141,2656,211Mar 05 05:23 PM
Oliveira OrlandoSVP & GM, InternationalMar 02Sale54.8633718,48812,076Mar 05 05:25 PM
Oliveira OrlandoSVP & GM, InternationalMar 01Option Exercise0.005,858012,413Mar 05 05:25 PM
MOULDER LEON O JRChief Executive OfficerMar 01Option Exercise0.0015,83601,034,664Mar 05 05:27 PM
Farmer Joseph LSr.VP,Gen.Counsel & SecretaryMar 01Option Exercise0.005,858010,488Mar 05 05:26 PM
Hedley Mary LynnePresident & COOMar 01Option Exercise0.0012,780018,853Mar 05 05:24 PM
Bogle Grant C.Sr. VP, Chief Commercial Ofc.Mar 01Option Exercise0.005,85806,240Mar 05 05:27 PM
Huber Martin H. Jr.SVP & Chief Medical OfficerMar 01Option Exercise0.005,858013,130Mar 05 05:25 PM
PEARSON TIMOTHY RExec. VP, CFOMar 01Option Exercise0.005,85808,786Mar 05 05:23 PM
Hedley Mary LynnePresident & COOMar 01Sale54.863,855211,48514,998Mar 05 05:24 PM
Bogle Grant C.Sr. VP, Chief Commercial Ofc.Mar 01Sale54.851,80999,2244,431Mar 05 05:27 PM